The relationship between CD44 expression and tumour grade is also uncertain, with a strong correlation between the Gleason grade of CaP and loss of CD44 expression in one study (De Marzo et al, 1998), but no correlation in another (Paradis et al, 1998). The gene discussed is CD44; the disease is neoplasm.